During the past decade, Xiamen Eye Center of Xiamen University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Xiamen Eye Center of Xiamen University" are "Blepharitis" (1 trials), "Dry Eye" (1 trials), "Polypoid Choroidal Vasculopathy (PCV)" (1 trials) and "Polypoidal Choroidal Vasculopathy (PCV)" (1 trials). Many other conditions were trialed in "Xiamen Eye Center of Xiamen University" in a lesser frequency.

Most popular intervention types in "Xiamen Eye Center of Xiamen University" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Conbercept" (1 trials), "HBM9036 0.25% Ophthalmic Solution" (1 trials), "Lotilaner" (1 trials), "Placebo" (1 trials) and "Vehicle Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xiamen Eye Center of Xiamen University" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Xiamen Eye Center of Xiamen University". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Xiamen Eye Center of Xiamen University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xiamen Eye Center of Xiamen University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".